3-[2-(3-Methylphenyl)pyrrolidine-1-carbonyl]-5-(propan-2-yl)-1,2-oxazole

Catalog No. :
ACTSUY858
CAS No. :
1031585-85-9
Molecular Formula :
C18H22N2O2
Molecular Weight :
298.39

IUPAC Name:(5-isopropylisoxazol-3-yl)(2-(m-tolyl)pyrrolidin-1-yl)methanone

3-[2-(3-Methylphenyl)pyrrolidine-1-carbonyl]-5-(propan-2-yl)-1,2-oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$281.00Login to see priceInquiryInquiry
250mg95%$579.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[2-(3-Methylphenyl)pyrrolidine-1-carbonyl]-5-(propan-2-yl)-1,2-oxazole
IUPAC Name(5-isopropylisoxazol-3-yl)(2-(m-tolyl)pyrrolidin-1-yl)methanone
MDL No.MFCD10702972
Molecular FormulaC18H22N2O2
Molecular Weight298.39
SMILESCC(C1=CC(C(N2C(C3=CC=CC(C)=C3)CCC2)=O)=NO1)C
InChI KeyYFNCLOHAGVKZIM-UHFFFAOYSA-N
Synonym3-[2-(3-methylphenyl)pyrrolidine-1-carbonyl]-5-(propan-2-yl)-1,2-oxazole;Methanone, [5-(1-methylethyl)-3-isoxazolyl][2-(3-methylphenyl)-1-pyrrolidinyl]-
CAS No.1031585-85-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTSUY858 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTSUY858 route product structure diagram
    ACTSUY8581031585-85-9
Inquiry

2. ACTSUY858 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTSUY858 route product structure diagram
    ACTSUY8581031585-85-9
Inquiry

Comments (0)